Analgesics - Serbia | Statista Market Forecast

In Serbia, the revenue generated in the Analgesics market is estimated to reach US$71.31m by 2024.
It is projected to experience an annual growth rate of 10.08% (CAGR 2024-2029).
Comparing globally, the United States generates the highest revenue, amounting to US$7.24bn in 2024.
When considering the population figures, the per person revenue in Serbia is approximately US$10.05 in 2024.
Serbia's analgesics market is witnessing a growing preference for locally produced herbal pain relief products.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Serbia has been experiencing steady growth in recent years, driven by several key factors. Customer preferences, local special circumstances, and underlying macroeconomic factors all play a role in shaping the trends and development of this market.Customer preferences in Serbia have been shifting towards a greater demand for over-the-counter (OTC) analgesics. This can be attributed to several factors, including the convenience and accessibility of OTC products, as well as the increasing awareness and importance of self-care among consumers. Additionally, the rising prevalence of chronic pain conditions and the aging population have also contributed to the growing demand for analgesics in Serbia.Trends in the market reflect these changing customer preferences. There has been a noticeable increase in the availability and variety of OTC analgesic products in Serbia. Pharmaceutical companies have been expanding their product portfolios to cater to this growing demand, offering a range of pain relief options including tablets, capsules, creams, and gels. Furthermore, there has been a shift towards the development of innovative analgesic formulations, such as extended-release formulations, which provide longer-lasting pain relief.Local special circumstances also influence the development of the Analgesics market in Serbia. The country's healthcare system, although improving, still faces challenges in terms of accessibility and affordability. As a result, many consumers turn to OTC analgesics as a more cost-effective and convenient alternative to prescription medications. Additionally, the presence of a large number of pharmacies and drugstores across the country ensures widespread availability of analgesic products to meet the needs of consumers.Underlying macroeconomic factors further contribute to the growth of the Analgesics market in Serbia. The country's improving economic conditions, along with rising disposable incomes, have increased the affordability of healthcare products, including analgesics. This has led to an increase in consumer spending on self-care and wellness products, driving the demand for analgesics.In conclusion, the Analgesics market in Serbia is developing in response to changing customer preferences, local special circumstances, and underlying macroeconomic factors. The shift towards OTC analgesics, the availability of a wide range of products, and the affordability of healthcare products have all contributed to the growth of this market. As the demand for analgesics continues to rise, pharmaceutical companies are likely to invest in further product development and innovation to meet the evolving needs of consumers in Serbia.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.